OTC Markets OTCPK - Delayed Quote USD

Astellas Pharma Inc. (ALPMY)

Compare
9.47
-0.07
(-0.73%)
At close: January 10 at 3:58:38 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ALPMY

Recent News: ALPMY

View More
U.S. FDA Confirms Class 1 Resubmission of the Supplemental New Drug Application for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy

U.S. FDA Confirms Class 1 Resubmission of the Supplemental New Drug Application for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
PR Newswire 4 days ago
China's National Medical Products Administration (NMPA) Approves PADCEV™ in combination with KEYTRUDA® (pembrolizumab) for the Treatment of Advanced Bladder Cancer

China's National Medical Products Administration (NMPA) Approves PADCEV™ in combination with KEYTRUDA® (pembrolizumab) for the Treatment of Advanced Bladder Cancer
PR Newswire 4 days ago
Astellas and Sangamo sign capsid deal for neurological diseases

Astellas and Sangamo sign capsid deal for neurological diseases
Pharmaceutical Technology 23 days ago
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases

Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
PR Newswire 24 days ago
Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases

Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Business Wire 24 days ago
Astellas and Dr. Jen Ashton launch "Cooler Moments" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves

Astellas and Dr. Jen Ashton launch "Cooler Moments" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves
PR Newswire last month
How Astellas juggles the moving parts of cancer precision medicine development

How Astellas juggles the moving parts of cancer precision medicine development
Pharma Voice last month
Astellas and DOHC partner to pilot digital solution for heart failure management

Astellas and DOHC partner to pilot digital solution for heart failure management
Medical Device Network last month
Astellas Announces Desert Oasis Healthcare as First Health System to Implement DIGITIVA™ for Heart Failure Management

Astellas Announces Desert Oasis Healthcare as First Health System to Implement DIGITIVA™ for Heart Failure Management
PR Newswire last month
FDA issues CRL to Astellas’ IZERVAY sNDA for geographic atrophy

FDA issues CRL to Astellas’ IZERVAY sNDA for geographic atrophy
Pharmaceutical Technology last month
Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer

Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
BioPharma Dive last month
View More

Related Tickers

DSNKY Daiichi Sankyo Company, Limited
25.97
-2.44%
 
KY4.DU Kyowa Kirin Co Ltd
13.80
0.00%
 
BRM.SG Bristol-Myers Squibb Co
54.47
-0.93%
 
AMGN.MX Amgen Inc.
5,390.00
0.00%
 
KYKOF Kyowa Kirin Co., Ltd.
15.00
+5.26%
 
CHGCY Chugai Pharmaceutical Co., Ltd.
21.10
-0.28%
 
OTSKY Otsuka Holdings Co., Ltd.
25.37
+0.02%
 
GIS.F Gilead Sciences, Inc.
88.68
+2.95%
 
SNY Sanofi
48.73
-1.02%
 
RHHBY Roche Holding AG
36.46
-0.27%